Eli Lilly (LLY) Current Taxes (2016 - 2025)
Historic Current Taxes for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $9.4 billion.
- Eli Lilly's Current Taxes changed N/A to $9.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 billion, marking a year-over-year change of. This contributed to the annual value of $1.1 billion for FY2024, which is N/A changed from last year.
- As of Q3 2025, Eli Lilly's Current Taxes stood at $9.4 billion.
- Over the past 5 years, Eli Lilly's Current Taxes peaked at $9.4 billion during Q3 2025, and registered a low of $126.6 million during Q2 2022.
- Over the past 5 years, Eli Lilly's median Current Taxes value was $791.6 million (recorded in 2021), while the average stood at $2.1 billion.
- As far as peak fluctuations go, Eli Lilly's Current Taxes plummeted by 8265.87% in 2021, and later soared by 87456.56% in 2023.
- Quarter analysis of 5 years shows Eli Lilly's Current Taxes stood at $126.9 million in 2021, then skyrocketed by 274.39% to $475.1 million in 2022, then skyrocketed by 316.23% to $2.0 billion in 2023, then tumbled by 43.54% to $1.1 billion in 2024, then surged by 745.97% to $9.4 billion in 2025.
- Its Current Taxes stands at $9.4 billion for Q3 2025, versus $7.0 billion for Q2 2025 and $6.2 billion for Q1 2025.